GENE L TRAN

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology VALENCIA, CA NPI 1003094046

General Payments — all program years on this page

$28,160.15

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 176
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $5,846.90 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $5,605.9210
EMD Serono, Inc. $190.576
Teva Pharmaceuticals USA, Inc. $37.301
Amgen Inc. $13.111

By program year

Program yearAmountRecords
2018 $374.0414
2019 $766.4825
2020 $526.9310
2021 $6,814.0747
2022 $8,575.8533
2023 $5,255.8829
2024 $5,846.9018

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1106238466 ABBVIE INC. $20.77 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106238468 ABBVIE INC. $102.27 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106238470 ABBVIE INC. $2,625.00 02/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1106238472 ABBVIE INC. $8.63 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106238474 ABBVIE INC. $26.47 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106238476 ABBVIE INC. $31.76 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106238478 ABBVIE INC. $125.02 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106238480 ABBVIE INC. $28.03 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106238482 ABBVIE INC. $2,625.00 10/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1106238484 ABBVIE INC. $12.97 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111727273 Amgen Inc. $13.11 04/23/2024 Education Undisputed 01/23/2026 View at CMS
1120215974 EMD Serono, Inc. $6.77 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120236530 EMD Serono, Inc. $50.38 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120247821 EMD Serono, Inc. $5.56 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120251556 EMD Serono, Inc. $6.25 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120255831 EMD Serono, Inc. $58.10 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120270802 EMD Serono, Inc. $63.51 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151626110 Teva Pharmaceuticals USA, Inc. $37.30 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.